Michael Gray, CFO & COO: Enliven Therapeutics ELVN Sell · Filed 23/02/22

Trade details

Type: Insider sale
Amount: $46,027.52
Shares · price: 9,856 sh · $4.67 a share
Held after: 27,610 sh
Stock: Enliven Therapeutics ELVN
Person: Michael GrayCFO & COO
Trade date: 23/02/22
Filed: 23/02/22
Days to filing: 0 days

Sold 26.3% of holdings

Share of holding sold: 26.3%

Enliven Therapeutics trades, last 26 weeks

What else happened in Enliven Therapeutics around then

Filed or reported within 30 days of the trade day · 23/01/23~23/03/24

Michael Gray's recent trades

Michael GrayCFO and COO
SellUpstream Bio
Sell
Upstream Bio
UPB
$5,203
853 sh
$5,203
Filed 06/17
Traded 06/16
Michael GrayCFO and COO
SellUpstream Bio
Sell
Upstream Bio
UPB
$7,915
852 sh
$7,915
Filed 03/17
Traded 03/16
Michael GrayCFO & COO
SellEnliven Therapeutics
Sell
Enliven Therapeutics
ELVN
$14.1K
3,596 sh
$14.1K
Filed 23/02/01
Traded 23/01/30